VeinViewer Technology Allows Clinicians to Assess Blood Patterns up to 15mm Deep
MEMPHIS, Tenn. – (November 4, 2014)
– Christie Medical Holdings, a global leader in mobile vein imaging systems, will exhibit its sixth generation VeinViewer®
at the annual American College of Phlebology (ACP) Congress November 6-8, in booth #210 at the JW Marriott Desert Ridge Resort in Phoenix. The ACP Congress is the largest annual gathering of vein specialists in the U.S. It brings together specialists in phlebology, vascular surgery, plastic surgery and more.
VeinViewer by Christie can be a valuable assessment tool for vascular procedures and surgeries. Using harmless, near-infrared light and digital full field technology, VeinViewer is able to project a real-time, HD image of a patient’s vasculature directly onto the surface of the skin.
VeinViewer allows clinicians to see blood patterns up to 15mm deep. Doctors can use the device to help them identify deeper, reticular veins—the kinds of veins that feed problem structures like varicose or spider veins. “VeinViewer helps when I am mapping vein targets before a procedure,” said Dr. Steven Heird, vascular surgeon and founder of the Advanced Vein & Laser Center in York, Pennsylvania. “It is must-have technology for anyone that considers themselves a vein specialist.” An early adopter of VeinViewer, Dr. Heird will lead a question-and-answer session about incorporating the technology into his practice. He will be in booth #210 at the ACP Congress Friday, November 8, noon to 1 p.m., and then again from 3-3:30 p.m.
“Doctors who specialize in vein treatment have to stay on the leading edge of technology,” said Product Manager Erin Shelton of Christie. “Not only does VeinViewer help provide more precise vein mapping through identification of deeper feeder veins, but it can also potentially help the clinician avoid secondary procedures. VeinViewer also provides a valuable asset for physicians in explaining the procedure during the consultation. Patients that are more informed may feel much more at ease.” Click video to see VeinViewer in use during a sclerotherapy procedure.
VeinViewer is the first and only device on the market to use: harmless near-infrared light, DLP® technologies, exclusive technology such as Active Vascular Imaging Navigation (AVIN™) which has been shown by clinical studies to increase both first stick success and patient satisfaction up to 100 percent while reducing medically unnecessary PICC lines by over 30 percent. VeinViewer’s TrueView imaging accuracy in projected vein-widths is three to ten times more accurate than the competition. With its Df2 (Digital full field) projection VeinViewer is able to provide a real-time, HD image of vasculature directly onto the surface of the skin.To learn more about Christie vein finding devices: VeinViewer Vision2, VeinViewer VisionXTND and VeinViewer Flex, please visit www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
Follow us on Twitter @christiemed
Christie® is a trademark of Christie Digital Systems USA, Inc., registered in the United States of America and certain other countries.
DLP® is a registered trademark of Texas Instruments.